- Home
- FEAM vs NTRB Comparison
FEAM vs NTRB Comparison
Compare FEAM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- NTRB
- Stock Information
- Founded
- FEAM 2016
- NTRB 2016
- Country
- FEAM United States
- NTRB United States
- Employees
- FEAM N/A
- NTRB N/A
- Industry
- FEAM Major Chemicals
- NTRB Industrial Specialties
- Sector
- FEAM Industrials
- NTRB Health Care
- Exchange
- FEAM Nasdaq
- NTRB Nasdaq
- Market Cap
- FEAM 46.9M
- NTRB 49.2M
- IPO Year
- FEAM N/A
- NTRB N/A
- Fundamental
- Price
- FEAM $0.69
- NTRB $5.89
- Analyst Decision
- FEAM Buy
- NTRB
- Analyst Count
- FEAM 4
- NTRB 0
- Target Price
- FEAM $4.19
- NTRB N/A
- AVG Volume (30 Days)
- FEAM 159.3K
- NTRB 47.2K
- Earning Date
- FEAM 11-07-2024
- NTRB 09-03-2024
- Dividend Yield
- FEAM N/A
- NTRB N/A
- EPS Growth
- FEAM N/A
- NTRB N/A
- EPS
- FEAM N/A
- NTRB N/A
- Revenue
- FEAM N/A
- NTRB $1,803,816.00
- Revenue This Year
- FEAM N/A
- NTRB N/A
- Revenue Next Year
- FEAM $1,117.19
- NTRB N/A
- P/E Ratio
- FEAM N/A
- NTRB N/A
- Revenue Growth
- FEAM N/A
- NTRB N/A
- 52 Week Low
- FEAM $0.40
- NTRB $1.53
- 52 Week High
- FEAM $3.35
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- FEAM 58.83
- NTRB 53.93
- Support Level
- FEAM $0.45
- NTRB $5.70
- Resistance Level
- FEAM $0.50
- NTRB $7.74
- Average True Range (ATR)
- FEAM 0.08
- NTRB 0.67
- MACD
- FEAM 0.04
- NTRB 0.03
- Stochastic Oscillator
- FEAM 72.73
- NTRB 38.53
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is engaged boron specialty advanced materials and lithium with a focus on enabling decarbonization, including electric transportation, clean energy, and food security.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.